(R) -Lisofylline
(R) -Lisofylline is a lysophosphatidic acid acyltransferase inhibitor (IC50 = 0.6 μM) that disrupts IL-12 signaling and STAT4 activation. It is a research tool used in studies of autoimmune disorders, including type 1 diabetes, and has been investigated in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
100324-81-0
Product Name Alternative
Diabetes, acid, acyltransferase, (R) Lisofylline, (R) -Lisofylline, (R) -Lisophylline, (R) Lisofylline, anti-inflammatory, IFN-γ, IL-12, inhibit, immunomodulator, Inhibitor, Lisofylline, Lisophylline, LPS, lysophosphatidic, metabolite, Pentoxifylline, STAT, STAT4
Field of Research
Signal Transduction, Stem Cell & Developmental Biology
Purity
99.50% (May vary between batches)
Solubility
DMSO:45 mg/mL (160.53 mM)
Smiles
C[C@@H] (O) CCCCn1c (=O) n (C) c2ncn (C) c2c1=O
Molecular Formula
C13H20N4O3
Molecular Weight
280.32
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
